Flowchart patient selection.

<p>Flowchart patient selection.</p

New findings and negative history: further investigations and diagnoses <i>(n = 33)</i>.

<p>New findings and negative history: further investigations and diagnoses <i>(n = 33)</i>.</p

Supplemental Data

Column A: 1=Intervention patient; 2=Control patient. Column B: Age on submission in years. Column C: 1=Male; 2=Female. Column D: LOS in days. Column E: Total nursing time for IV treatment in minutes. Column F: Total price of antibiotic therapy in Euros. Column G: Total DDDs of antibiotic therapy. Column H: 1=DRG Group 1; 2=DRG Group 2

Supplemental Data

Column A: 1=Intervention patient; 2=Control patient. Column B: Age on submission in years. Column C: 1=Male; 2=Female. Column D: LOS in days. Column E: Total nursing time for IV treatment in minutes. Column F: Total price of antibiotic therapy in Euros. Column G: Total DDDs of antibiotic therapy. Column H: 1=DRG Group 1; 2=DRG Group 2

Probabilistic Sensitivity Analysis for DRG Group 1.

<p>Depicted is the probability of the costs or benefits in Euros with a PSA done for LOS, nursing time and antibiotic costs. The model ran for 2500 repeats. The 95% confidence interval is represented with the two dashed lines.</p

Surface graphs showing different parameter ranges.

<p>All graphs show a range of the hospital day price on the Y-axis with another parameter on the X-axis. The color represents the costs or benefits ranging from minus €200 in dark red to €1400 in dark green; the dashed line indicates €0. The total value for the UMCG, using the urology study values is shown in every plot. A: Range of baseline average of LOS before starting with an A-Team. B: Range of percentage of patients primarily administered with an infection. C: Range of costs of 1 consultation. D: Range of percentage of expected LOS reduction through A-Team interventions.</p

Model parameters.

<p>Model parameters.</p